KYMR
Kymera Therapeutics Inc Earnings
$43.43
Earnings Summary
Revenue | $22.1Mn |
Net Profits | $-65.58Mn |
Net Profit Margins | -296.75% |
Kymera Therapeutics Inc’s revenue jumped 114.83% since last year same period to $22.1Mn in the Q1 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated 198.89% jump in its revenue since last 3-months.
Kymera Therapeutics Inc’s net profit fell -35.06% since last year same period to $-65.58Mn in the Q1 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated 7.31% jump in its net profits since last 3-months.
Kymera Therapeutics Inc’s net profit margin jumped 37.13% since last year same period to -296.75% in the Q1 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated 68.99% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.82 |
EPS Estimate Current Year | -0.82 |
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a -11.79% fall from last quarter’s estimates.
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.82.
Key Ratios
Earning Per Share (EPS) | 0 |
Kymera Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Kymera Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-01 | -0.82 | 0 | 100% |
2025-05-09 | -0.73 | -0.82 | -12.33% |
